DARE Dare Bioscience, Inc. - Common Stock
NASDAQ · Pharmaceuticals · Visualizza su SEC EDGAR ↗ chiudi Ott 2, 2026 10-K/10-Q Ago 13, 2026
$0,84
· % dell'intervallo 52 sett.
· sopra il minimo
· al massimo
$0,69minimo 52 sett.
$3,78massimo 52 sett.
Capitalizzazione di Mercato (MRQ)
$13M
P/E (TTM)
-1.3
EPS (TTM)
$-0.66
Ricavi (TTM)
$1M
i tuoi badge
Intervallo 52 sett.
$1–$4
Rating Analisti
BUY
Prezzo Obiettivo
$8
P/E
-1.3
ROE
165.3%
Margine di Profitto Netto
-804.4%
La tua barra dei badge è vuota — aggiungi una metrica a piacere in questa pagina.
DARE Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$0.84
Capitalizzazione di Mercato (MRQ)
$13M
P/E (TTM)
-1.3
EPS (TTM)
$-0.66
Ricavi (TTM)
$1M
ROE (TTM)
165.3%
Intervallo 52 sett.
$1–$4
DARE Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
intervallo
barre
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
Split azionari
| Data ex-dividendo | Split | Tipo |
|---|---|---|
| 01 Luglio 2024 | 1-for-12 | Inverso |
| 20 Luglio 2017 | 1-for-10 | Inverso |
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi$1M2016-12-31 → 2025-12-31
EPS$-1.202020-12-31 → 2025-12-31
Flusso di cassa libero$-10M2016-12-31 → 2025-12-31
Margine netto-804.4%2016-12-31 → 2025-12-31
Valutazione e Rapporti
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
| Metrica | Tendenza 5 anni | DARE | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| P/E (TTM) | -1.3media 5 anni ≈-14.8 | ≈-14.8 | · | · | |
| P/S (TTM) | 9.4media 5 anni ≈754.5 | ≈754.5 | 18.4 | Sopravvalutato | |
| P/B (MRQ) | -22.8media 5 anni ≈12.0 | ≈12.0 | · | · | |
| Prezzo / FCF (TTM) | -1.1media 5 anni ≈-24.6 | ≈-24.6 | · | · | |
| Prezzo / Flusso di cassa (TTM) | -1.1media 5 anni ≈-24.8 | ≈-24.8 | · | · | |
| Price / Tangible Book (Prezzo / Valore contabile tangibile) | 4.3media 5 anni ≈46.0 | ≈46.0 | · | · |
La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
| Metrica | Tendenza 5 anni | DARE | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Margine Operativo (TTM) | -813.4%media 5 anni ≈-60605.9% | ≈-60605.9% | -1538.8% | In linea | |
| Margine EBITDA (TTM) | -656.5%media 5 anni ≈-60566.2% | ≈-60566.2% | -1495.1% | Debole | |
| Pretax Margin (Margine ante imposte) | -1314.4%media 5 anni ≈-11028.1% | ≈-11028.1% | -998.5% | Debole | |
| Margine di Profitto Netto (TTM) | -804.4%media 5 anni ≈-11028.8% | ≈-11028.8% | -1379.6% | Debole | |
| ROA (TTM) | -62.2%media 5 anni ≈-68.9% | ≈-68.9% | -49.1% | In linea | |
| ROE (TTM) | 165.3%media 5 anni ≈185.3% | ≈185.3% | -57.8% | Di prim'ordine | |
| ROIC | -476.8%media 5 anni ≈28.6% | ≈28.6% | 145.2% | Debole |
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
| Metrica | Tendenza 5 anni | DARE | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Rapporto corrente (MRQ) | 1.0media 5 anni ≈1.5 | ≈1.5 | 3.1 | Bassa liquidità | |
| Quick Ratio | 1.0media 5 anni ≈1.3 | ≈1.3 | 2.1 | Bassa liquidità |
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
| Metrica | Tendenza 5 anni | DARE | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Revenue YoY (Ricavi YoY) | 10429.4%media 5 anni ≈3419.3% | ≈3419.3% | · | · | |
| Revenue CAGR 3Y (CAGR Ricavi 3Y) | -53.1% | · | · | · |
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
| Metrica | Tendenza 5 anni | DARE | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Asset Turnover (Rotazione delle attività) | 0.0media 5 anni ≈0.1 | ≈0.1 | 0.1 | Debole | |
| Revenue / Employee (Ricavi / Dipendente) | ≈$49.1K | · | · | · |
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
27.3%
Prossimo report
Nov 11, 2026
| Periodo | Rapporto | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|---|
| 30 Giugno 2026 | Ago 13, 2026 | $-0.20 | $-0.25 | 20.0% |
| 31 Marzo 2026 | Mag 14, 2026 | $-0.20 | $-0.30 | 32.4% |
| 31 Dicembre 2025 | $-0.02 | $-0.44 | 95.5% | |
| 30 Settembre 2025 | $-0.28 | $-0.36 | 23.0% | |
| 30 Giugno 2025 | $-0.45 | $-0.59 | 23.9% | |
| 31 Marzo 2025 | $-0.50 | $-0.59 | 15.5% | |
| 31 Dicembre 2024 | $-0.65 | $-0.54 | -19.5% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1M | $9.8K | $3M | $10M | $0 | · | · | · | · | $766.0K | · | $80.0K | |
| Cost of Revenue | $295.8K | $0 | · | · | · | · | · | · | · | · | · | · | |
| R&D Expense | $6M | $14M | $22M | $30M | $31M | $21M | $9M | $6M | $984.7K | $72.7K | $26M | $12M | |
| SG&A Expense | $9M | $9M | $12M | $11M | $8M | $7M | $5M | $5M | $3M | $157.9K | $11M | $9M | |
| Operating Expenses | $14M | $23M | $34M | $41M | $39M | $27M | $14M | $17M | $11M | $630.6K | $37M | $20M | |
| Operating Income | $-14M | $-23M | $-31M | $-31M | $-39M | $-27M | $-14M | $-17M | $-11M | $-630.6K | · | · | |
| Interest Expense | · | · | · | · | · | · | · | · | $322.6K | $42.1K | $2M | $1M | |
| Interest Income | · | · | · | · | · | · | · | · | · | $86.0K | $10.0K | $9.0K | |
| Other Non-op | $-153.1K | $981.5K | $778.5K | $437.8K | $2.5K | $1.5K | $81.0K | $143.5K | $-322.6K | $-2M | $-2M | $-3M | |
| Pretax Income | $-14M | $-4M | $-30M | $-31M | $-39M | $-27M | $-14M | $-17M | $-12M | $-673.0K | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $3.2K | $0 | · | · | · | |
| Net Income | $-13M | $-4M | $-30M | $-31M | $-39M | $-27M | $-14M | $-17M | $-12M | $-672.7K | $-40M | $-23M | |
| EPS (Basic) | $-1.20 | $-0.48 | $-4.15 | $-0.37 | $-0.63 | $-0.91 | · | · | · | · | · | · | |
| EPS (Diluted) | $-1.20 | $-0.48 | $-4.15 | $-0.37 | $-0.63 | $-0.91 | · | · | · | · | · | · | |
| Shares (Basic) | 11,178,752 | 8,497,459 | 7,275,308 | 84,571,805 | 61,154,157 | 30,091,469 | · | · | 3,232,278 | 835,000 | · | · | |
| Shares (Diluted) | 11,178,752 | 8,497,459 | 7,275,308 | 84,571,805 | 61,154,157 | 30,091,469 | · | · | 3,232,278 | 835,000 | · | · | |
| EBITDA | $-12M | $-23M | $-31M | $-31M | $-39M | $-27M | $-14M | $-17M | · | $261.0K | $192.0K | $126.0K |
Stato Patrimoniale
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $25M | $16M | $10M | $35M | $52M | $5M | $5M | $7M | $8M | $44.6K | $219.4K | $51M | |
| Receivables | · | · | · | · | $0 | · | · | · | · | $823.0K | · | · | |
| Prepaid Expense | $387.1K | $3M | $6M | $7M | $2M | $2M | $1M | $403.1K | $311.6K | $1M | · | · | |
| Other Current Assets | $573.1K | $0 | $0 | $0 | · | · | · | $0 | $193.5K | · | · | · | |
| Current Assets | $27M | $18M | $18M | $43M | $55M | $7M | $6M | $7M | $8M | $44.6K | $77M | $53M | |
| PP&E (Net) | $2M | $1M | $656.0K | $64.9K | $26.0K | $37.9K | $63.5K | $9.4K | $0 | $668.0K | $576.0K | $342.0K | |
| PP&E (Gross) | $2M | $2M | $801.7K | · | · | · | · | · | · | $2M | $2M | $2M | |
| Accum. Depreciation | $338.0K | $175.9K | $145.7K | · | · | · | · | · | · | $1M | $1M | $1M | |
| Goodwill | · | · | · | · | · | · | · | $0 | $5M | · | · | · | |
| Other Non-current Assets | $1M | $1M | $599.6K | $254.3K | $485.1K | $528.9K | $935.3K | $578.0K | $723.2K | $12.7K | $347.0K | $215.0K | |
| Total Assets | $32M | $22M | $21M | $44M | $56M | $8M | $7M | $8M | $14M | $44.6K | $78M | $53M | |
| Accounts Payable | $1M | $1M | $3M | $2M | $2M | $1M | $1M | $459.7K | $308.2K | $12.7K | $2M | $1M | |
| Accrued Liabilities | $725.2K | $3M | $3M | $11M | $3M | $3M | $2M | $631.4K | $658.4K | $5M | $6M | $4M | |
| Short-term Debt | · | · | · | · | $0 | $367.3K | $0 | · | · | · | · | · | |
| Current Liabilities | $24M | $22M | $20M | $32M | $16M | $8M | $6M | $1M | $966.7K | $755.2K | $16M | $8M | |
| Capital Leases | $559.4K | $754.4K | $935.7K | $90.3K | $0 | $41.8K | $389.6K | $389.0K | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | $0 | $41.8K | $389.6K | $9.7K | · | $1M | $473.0K | $7.0K | |
| Total Liabilities | $30M | $28M | $26M | $33M | $17M | $9M | $7M | $1M | $967.0K | $755.2K | · | · | |
| Total Debt | · | · | · | · | $0 | $367.3K | · | · | · | · | · | · | |
| Common Stock | $1.4K | $870 | $833 | $8.5K | $8.4K | $4.2K | $2.0K | $1.1K | $605 | $91 | $3.0K | $2.0K | |
| Paid-in Capital | $192M | · | · | · | · | · | · | · | · | · | · | $167M | |
| Retained Earnings | $-189M | $-175M | $-171M | $-141M | $-110M | $-71M | $-44M | $-29M | $-12M | $-727.8K | $-161M | $-122M | |
| AOCI | $-421.6K | $-428.8K | $-360.9K | $-351.3K | $-155.0K | $-91.4K | $-102.6K | $-96.7K | $-18.1K | · | · | · | |
| Stockholders' Equity | $3M | $-6M | $-5M | $11M | $39M | $-1M | $440.8K | $7M | $13M | $-710.6K | $-46.9K | $45M | |
| Liabilities + Equity | $32M | $22M | $21M | $44M | $56M | $8M | $7M | $8M | $14M | $44.6K | $78M | $53M | |
| Shares Outstanding | 14,499,502 | 8,700,386 | 8,331,161 | 7,068,790 | 83,944,119 | 41,596,253 | 19,683,401 | 11,422,161 | 6,047,161 | 910,000 | 27,346,780 | 20,125,049 |
Flusso di cassa
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $42.3K | · | · | · | · | · | · | · | $261.0K | $192.0K | $126.0K | |
| Stock-based Comp | $1M | $2M | $3M | $2M | $2M | $742.0K | $462.2K | $139.3K | $15.8K | $9.0K | $2M | $885.0K | |
| Other Non-cash | $382.4K | · | · | · | · | · | · | · | · | $3M | $5M | $3M | |
| Operating Cash Flow | $-10M | $5M | $-39M | $-18M | $-29M | $-25M | $-13M | $-10M | $-3M | $-372.3K | $-32M | $-19M | |
| CapEx | $385.3K | $573.0K | $629.4K | $63.1K | $14.5K | $17.6K | $0 | $11.8K | $0 | $535.0K | $277.0K | $225.0K | |
| Investing Cash Flow | $-385.3K | $-573.0K | $-629.4K | $-63.1K | $-14.5K | $-17.6K | $6M | $-518.8K | $10M | · | · | · | |
| Stock Issued | $21M | $453.6K | · | $1M | $16M | $23M | $5M | · | · | $918.0K | $3M | $140.0K | |
| Net Stock Activity | $21M | · | · | $1M | $16M | $23M | · | · | · | $918.0K | $3M | $140.0K | |
| Financing Cash Flow | $19M | $354.5K | $16M | $1M | $76M | $25M | $5M | $10M | $155.0K | · | · | · | |
| Net Change in Cash | $9M | $5M | $-24M | $-17M | $47M | $-110.6K | $-2M | $-754.0K | $8M | $-174.8K | $25M | $46M | |
| Free Cash Flow | $-10M | $5M | $-39M | $-18M | $-29M | $-25M | $-13M | $-10M | · | $-34M | $-32M | $-19M |
Redditività
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1315.5% | -239692.2% | -1101.9% | -313.9% | · | · | · | · | · | · | · | · | |
| Net Margin | -1300.7% | -41430.9% | -1074.2% | -309.5% | · | · | · | · | · | -5131.2% | · | -29177.5% | |
| Pretax Margin | -1314.4% | -41414.6% | -1074.1% | -309.5% | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -1156.9% | -239692.2% | -1101.9% | -313.9% | · | · | · | · | · | 34.1% | · | 157.5% | |
| ROA | -49.1% | -18.7% | -92.7% | -62.1% | -122.2% | -365.5% | -186.8% | -151.6% | · | -67.8% | -60.2% | -77.5% | |
| ROE | 270.9% | 108.1% | 822.2% | -165.2% | -109.5% | 2159.6% | -1267.4% | -205.3% | · | -601.7% | -84.2% | 95.3% | |
| ROIC | -476.8% | 390.1% | 613.0% | -282.4% | -100.8% | 3493.2% | -3254.1% | -251.0% | · | · | · | · |
Liquidità e Solvibilità
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 0.9 | 0.9 | 1.4 | 3.4 | 0.9 | 1.1 | 6.6 | · | 2.2 | 4.7 | 6.6 | |
| Quick Ratio | 1.0 | 0.7 | 0.5 | 1.1 | 3.2 | 0.6 | 0.9 | 6.2 | · | 2.1 | 4.6 | 6.3 | |
| Debt / Equity | · | · | · | · | 0.0 | -0.3 | · | · | · | · | · | · |
Efficienza
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.1 | 0.2 | · | · | · | · | · | 0.0 | · | 0.0 |
Per Azione
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.20 | $-0.69 | $-0.05 | $0.13 | $0.46 | $-0.03 | $0.02 | $0.59 | · | $0.45 | $1.78 | $2.25 | |
| Revenue / Share | $0.09 | $0.00 | $0.03 | $0.12 | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-0.88 | $0.63 | $-0.45 | $-0.21 | $-0.47 | · | · | · | · | · | · | · | |
| Cash / Share | $1.70 | $1.80 | $0.10 | $0.41 | $0.62 | $0.11 | $0.24 | $0.60 | · | $1.21 | $2.78 | $2.54 | |
| EPS (TTM) | $-1.20 | $-0.48 | $-4.15 | $-0.37 | $-0.63 | $-0.91 | · | · | · | · | · | · |
Tassi di Crescita
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 10429.4% | -99.7% | -71.9% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -53.1% | · | · | · | · | · | · | · | · | · | · | · |
Valutazione (TTM)
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1M | $9.8K | $3M | $10M | $0 | · | · | · | · | $766.0K | · | $80.0K | |
| Net Income TTM | $-13M | $-4M | $-30M | $-31M | $-39M | $-27M | $-14M | $-17M | $-12M | $-672.7K | $-40M | $-23M | |
| Market Cap | $28M | $27M | $371M | $845M | $2.01B | $669M | $194M | $97M | · | $2.46B | $9.19B | $15.02B | |
| Enterprise Value | · | · | · | · | $1.96B | $665M | · | · | · | · | · | · | |
| P/E | -1.6 | -6.5 | -0.9 | -26.9 | -38.1 | -17.7 | · | · | · | · | · | · | |
| P/S | 27.2 | 2774.4 | 132.0 | 84.5 | · | · | · | · | · | 3209.5 | · | 187766.7 | |
| P/B | 9.8 | -4.5 | -73.4 | 76.0 | 52.0 | -580.7 | 439.4 | 14.5 | · | 187.5 | 188.5 | 331.4 | |
| P / Tangible Book | 9.8 | · | · | 76.0 | 52.0 | · | · | · | · | · | · | · | |
| P / Cash Flow | -2.8 | 5.0 | -9.5 | -46.7 | -70.0 | -26.5 | -14.5 | -9.5 | · | -73.3 | -287.9 | -788.1 | |
| P / FCF | -2.7 | 5.6 | -9.4 | -46.5 | -70.0 | -26.5 | -14.5 | -9.5 | · | -72.2 | -285.4 | -778.9 | |
| EV / EBITDA | · | · | · | · | -50.2 | -24.3 | · | · | · | · | · | · | |
| EV / FCF | · | · | · | · | -68.2 | -26.3 | · | · | · | · | · | · | |
| Earnings Yield | -62.2% | -15.4% | -111.9% | -3.7% | -2.6% | -5.7% | · | · | · | · | · | · |
Conto Economico
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $187.5K | $152.5K | $1M | $2.3K | $-21.2K | $25.4K | $-63.6K | $41.7K | $22.4K | $9.3K | $2M | $1M | $0 | $0 | $0 | $0 | |
| Cost of Revenue | $319.9K | $242.3K | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| R&D Expense | $242.0K | $660.5K | $622.0K | $1M | $1M | $2M | $3M | $3M | $5M | $3M | $4M | $7M | $6M | $5M | $13M | $4M | |
| SG&A Expense | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Operating Expenses | $3M | $3M | $2M | $4M | $4M | $5M | $5M | $5M | $7M | $6M | $7M | $9M | $9M | $8M | $16M | $7M | |
| Operating Income | $-3M | $-3M | $-1M | $-4M | $-4M | $-5M | $-5M | $-5M | $-7M | $-6M | $-5M | $-8M | $-9M | $-8M | $-16M | $-7M | |
| Other Non-op | $-14.8K | $-991 | $-276.6K | $109.4K | $-188.7K | $202.8K | $2M | $-21.2K | $-109.3K | $-732.9K | $113.9K | $97.3K | $227.1K | $340.1K | $287.3K | $119.0K | |
| Net Income | $-3M | $-3M | $-1M | $-4M | $-4M | $-4M | $-6M | $-5M | $13M | $-7M | $-5M | $-8M | $-9M | $-8M | $-16M | $-7M | |
| EPS (Basic) | $-0.20 | $-0.21 | $0.03 | $-0.28 | $-0.45 | $-0.50 | $-0.65 | $-0.55 | $1.53 | $-0.81 | $-1.75 | $-1.09 | $-1.22 | $-0.09 | $-0.19 | $-0.08 | |
| EPS (Diluted) | $-0.20 | $-0.21 | $0.03 | $-0.28 | $-0.45 | $-0.50 | $-0.64 | $-0.55 | $1.52 | $-0.81 | $-1.75 | $-1.09 | $-1.22 | $-0.09 | $-0.19 | $-0.08 | |
| Shares (Basic) | 14,889,832 | 14,522,835 | · | 12,755,112 | 8,871,155 | 8,759,053 | · | 8,534,433 | 8,411,242 | 8,376,189 | · | 7,587,637 | 7,200,260 | 85,517,540 | · | 84,822,516 | |
| Shares (Diluted) | 14,889,832 | 14,522,835 | · | 12,755,112 | 8,871,155 | 8,759,053 | · | 8,534,433 | 8,476,231 | 8,376,189 | · | 7,587,637 | 7,200,260 | 85,517,540 | · | 84,822,516 | |
| EBITDA | $-3M | $-2M | · | $-4M | $-4M | $-4M | · | $-5M | $-7M | $-6M | · | $-8M | $-9M | $-8M | · | $-7M |
Stato Patrimoniale
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $13M | $19M | $25M | $23M | $5M | $10M | $16M | $11M | $16M | $4M | $10M | $14M | $13M | $20M | $35M | $40M | |
| Prepaid Expense | $835.4K | $680.8K | $2M | $2M | $1M | $1M | $3M | $3M | $4M | $5M | $6M | $7M | $8M | $7M | $7M | $7M | |
| Other Current Assets | $456.4K | $687.8K | · | $53.2K | · | · | · | · | · | $152.2K | · | $831.4K | $272.1K | $201.4K | · | · | |
| Current Assets | $17M | $22M | $27M | $25M | $7M | $12M | $18M | $15M | $21M | $10M | $18M | $22M | $22M | $30M | $43M | $50M | |
| PP&E (Net) | $1M | $1M | $2M | $2M | $2M | $1M | $1M | $706.3K | $322.3K | $52.5K | $656.0K | $58.6K | $45.8K | $55.4K | $64.9K | $72.8K | |
| PP&E (Gross) | · | · | $2M | · | · | · | $2M | · | · | · | $801.7K | · | · | · | · | · | |
| Accum. Depreciation | · | · | $338.0K | · | · | · | $175.9K | · | · | · | $145.7K | · | · | · | · | · | |
| Other Non-current Assets | $3M | $2M | $1M | $1M | $1M | $1M | $1M | $533.9K | $528.6K | $654.5K | $599.6K | $796.4K | $920.9K | $799.3K | $254.3K | $736.5K | |
| Total Assets | $22M | $28M | $32M | $31M | $13M | $19M | $22M | $18M | $24M | $13M | $21M | $25M | $23M | $30M | $44M | $50M | |
| Accounts Payable | $762.9K | $1M | $1M | $2M | $2M | $2M | $1M | $1M | $2M | $4M | $3M | $5M | $7M | $3M | $2M | $3M | |
| Accrued Liabilities | $448.9K | $529.3K | $725.2K | $2M | $3M | $2M | $3M | $2M | $1M | $1M | $3M | $5M | $4M | $5M | $11M | $4M | |
| Current Liabilities | $17M | $21M | $24M | $21M | $19M | $21M | $22M | $13M | $15M | $18M | $20M | $26M | $25M | $24M | $32M | $23M | |
| Capital Leases | $273.9K | $418.3K | $559.4K | $288.6K | $448.2K | $603.3K | $754.4K | $897.8K | $1M | $1M | $935.7K | $0 | $23.3K | $57.1K | $90.3K | $194.6K | |
| Total Liabilities | $23M | $27M | $30M | $28M | $26M | $28M | $28M | $20M | $21M | $24M | $26M | $27M | $26M | $25M | $33M | $24M | |
| Total Debt | · | · | · | $10.5K | $188.0K | $91.9K | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $1.5K | $1.5K | $1.4K | $1.4K | $903 | $885 | $870 | $854 | $854 | $10.1K | $833 | $9.8K | $8.7K | $8.6K | $8.5K | $8.5K | |
| Paid-in Capital | $194M | $193M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Retained Earnings | $-195M | $-192M | $-189M | $-187M | $-184M | $-180M | $-175M | $-170M | $-165M | $-178M | $-171M | $-166M | $-158M | $-149M | $-141M | $-125M | |
| AOCI | $-374.9K | $-377.1K | $-421.6K | $-396.0K | $-402.8K | $-415.7K | $-428.8K | $-362.6K | $-385.6K | $-400.1K | $-360.9K | $-419.5K | $-404.5K | $-373.3K | $-351.3K | $-530.7K | |
| Stockholders' Equity | $-560.1K | $734.5K | $3M | $3M | $-13M | $-10M | $-6M | $-1M | $3M | $-11M | $-5M | $-2M | $-3M | $5M | $11M | $26M | |
| Liabilities + Equity | $22M | $28M | $32M | $31M | $13M | $19M | $22M | $18M | $24M | $13M | $21M | $25M | $23M | $30M | $44M | $50M | |
| Shares Outstanding | 15,169,502 | 14,559,502 | 14,499,502 | 13,929,502 | 9,030,386 | 8,850,386 | 8,700,386 | 8,546,364 | 8,546,361 | 100,581,900 | 8,331,161 | 98,292,344 | 86,633,588 | 86,178,996 | 84,825,481 | 83,944,119 |
Flusso di cassa
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $572.1K | $554.6K | $534.4K | $481.9K | $460.1K | $175.6K | $6.4K | $9.7K | $15.4K | $10.8K | · | · | · | · | · | · | |
| Stock-based Comp | $286.6K | $455.1K | $357.2K | $403.0K | $359.0K | $377.4K | $489.3K | $523.6K | $562.7K | $627.7K | $619.8K | $636.1K | $650.2K | $624.6K | $532.1K | $556.4K | |
| Other Non-cash | · | $-4M | · | · | · | $-2M | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-7M | $-6M | $1M | $-442.1K | $-5M | $-5M | $5M | $-6M | $13M | $-7M | $-8M | $-8M | $-7M | $-16M | $-6M | $9M | |
| CapEx | $80.6K | $0 | $206.6K | $174.7K | $-153.4K | $157.3K | $562.8K | $-282.3K | $285.2K | $7.3K | $607.3K | $22.1K | $0 | $0 | $2.7K | $55.0K | |
| Investing Cash Flow | $-80.6K | $0 | $-206.6K | $-174.7K | $153.4K | $-157.3K | $-562.8K | $282.3K | $-285.2K | $-7.3K | $-607.3K | $-22.1K | $0 | $0 | $-2.7K | $-55.0K | |
| Stock Issued | $166.7K | $94.9K | · | · | $475.0K | $436.2K | · | · | · | · | · | · | · | · | · | $0 | |
| Net Stock Activity | · | $94.9K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $951.2K | $-715.5K | $424.1K | $19M | $-43.8K | $246.6K | $-211.3K | $436.4K | $115.4K | $14.0K | $5M | $9M | $452.2K | $1M | $-1 | $4.5K | |
| Net Change in Cash | $-6M | $-6M | $2M | $18M | $-5M | $-5M | $4M | $-5M | $13M | $-7M | $-3M | $565.3K | $-6M | $-15M | $-6M | $8M | |
| Free Cash Flow | · | $-6M | · | · | · | $-6M | · | · | · | $-7M | · | · | · | $-16M | · | · |
Redditività
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1582.5% | -1967.1% | · | -162340.8% | · | -18016.8% | · | -11228.7% | -32799.1% | -64743.8% | · | -839.6% | · | · | · | · | |
| Net Margin | -1590.4% | -1967.7% | · | -157505.1% | · | -17219.1% | · | -11279.4% | 57539.3% | -72622.6% | · | -829.9% | · | · | · | · | |
| EBITDA Margin | -1582.5% | -1603.3% | · | -162340.8% | · | -17394.9% | · | -11228.7% | -32799.1% | -64743.8% | · | -839.6% | · | · | · | · | |
| ROA | -16.9% | -12.9% | · | -14.6% | -22.0% | -27.7% | · | -21.8% | 55.1% | -31.1% | · | -22.0% | -23.5% | -20.2% | · | -14.1% | |
| ROE | 44.9% | 68.0% | · | -518.8% | 79.8% | 42.6% | · | 249.3% | -53911.2% | 224.1% | · | -69.0% | -57.8% | -44.9% | · | -24.1% |
Liquidità e Solvibilità
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.0 | 1.0 | · | 1.2 | 0.3 | 0.6 | · | 1.1 | 1.4 | 0.6 | · | 0.9 | 0.9 | 1.2 | · | 2.2 | |
| Quick Ratio | 0.7 | 0.9 | · | 1.1 | 0.3 | 0.5 | · | 0.9 | 1.1 | 0.2 | · | 0.5 | 0.5 | 0.8 | · | 1.8 | |
| Debt / Equity | · | · | · | 0.0 | -0.0 | -0.0 | · | · | · | · | · | · | · | · | · | · |
Efficienza
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | · | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | 0.0 |
Per Azione
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-0.04 | $0.05 | · | $0.21 | $-1.41 | $-1.08 | · | $-0.17 | $0.31 | $-0.11 | · | $-0.02 | $-0.03 | $0.06 | · | $0.31 | |
| Revenue / Share | $0.01 | $0.01 | · | $0.00 | · | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.01 | $0.00 | · | · | $0.00 | |
| Cash Flow / Share | · | $-0.38 | · | · | · | $-0.62 | · | · | · | $-0.07 | · | · | · | $-0.19 | · | · | |
| Cash / Share | $0.83 | $1.27 | · | $1.66 | $0.56 | $1.17 | · | $1.31 | $1.92 | $0.04 | · | $0.14 | $0.15 | $0.23 | · | $0.48 | |
| EPS (TTM) | $-0.66 | $-0.91 | · | $-1.87 | $-2.14 | $-0.17 | · | $-1.59 | $-2.13 | $-4.87 | · | $-2.59 | $-1.58 | $-0.36 | · | $-0.29 |
Valutazione (TTM)
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1M | $1M | · | $-57.1K | $-17.7K | $25.9K | · | $2M | $3M | $3M | · | $1M | $0 | $10M | · | · | |
| Net Income TTM | $-11M | $-12M | · | $-17M | $-19M | $-2M | · | $-4M | $-7M | $-29M | · | $-41M | $-40M | $-31M | · | $-25M | |
| Market Cap | $32M | $26M | · | $29M | $22M | $26M | · | $28M | $34M | $591M | · | $545M | $946M | $1.08B | · | $1.01B | |
| Enterprise Value | · | · | · | $6M | $17M | $15M | · | · | · | · | · | · | · | · | · | · | |
| P/E | -3.2 | -2.0 | · | -1.1 | -1.1 | -17.0 | · | -2.0 | -1.9 | -1.2 | · | -2.1 | -6.9 | -34.7 | · | -41.4 | |
| P/S | 23.4 | 22.9 | · | -512.0 | -1219.3 | 987.2 | · | 14.7 | 12.1 | 209.9 | · | 544.9 | · | 107.6 | · | · | |
| P/B | -57.1 | 36.1 | · | 10.2 | -1.7 | -2.7 | · | -18.7 | 12.9 | -53.8 | · | -238.1 | -347.9 | 216.3 | · | 38.2 | |
| P / Tangible Book | · | 36.1 | · | 10.2 | · | · | · | · | 12.9 | · | · | · | · | 216.3 | · | 38.2 | |
| P / Cash Flow | · | -4.8 | · | · | · | -4.7 | · | · | · | -86.8 | · | · | · | -66.7 | · | · | |
| EV / Revenue | · | · | · | -108.3 | -945.5 | 592.1 | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -31.3% | -50.0% | · | -89.0% | -89.5% | -5.9% | · | -49.1% | -52.8% | -82.8% | · | -46.7% | -14.5% | -2.9% | · | -2.4% |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ricavi | $1M | $9.8K | $3M | $10M | $0 |
| Margine Operativo % | -1315.5% | -239692.2% | -1101.9% | -313.9% | · |
| Utile netto | $-13M | $-4M | $-30M | $-31M | $-39M |
| EPS Diluito | $-1.20 | $-0.48 | $-4.15 | $-0.37 | $-0.63 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto | · | · | · | · | 0.0 |
| Rapporto corrente | 1.1 | 0.9 | 0.9 | 1.4 | 3.4 |
| Quick Ratio | 1.0 | 0.7 | 0.5 | 1.1 | 3.2 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flusso di cassa libero | $-10M | $5M | $-39M | $-18M | $-29M |
Proprietari istituzionali (13F) 30 filer · $4.2M totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Detentori
30
Valore detenuto
$4.2M
Nuove posizioni
7
Posizioni chiuse
5
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 7 (0 vs trimestre precedente) | 5 (-2 vs trimestre precedente) | 11 (+5 vs trimestre precedente) | 4 (+1 vs trimestre precedente) | +277K |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $1.352.250 | 640.877 | 32,42% | Azioni |
| VANGUARD GROUP INC | $1.009.492 | 523.053 | 24,20% | Azioni |
| AMH Equity Ltd | $487.983 | 232.373 | 11,70% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $295.642 | 140.093 | 7,09% | Azioni |
| US BANCORP \DE\ | $255.141 | 120.920 | 6,12% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $192.578 | 91.269 | 4,62% | Azioni |
| BlackRock, Inc. | $135.564 | 64.248 | 3,25% | Azioni |
| STATE STREET CORP | $100.046 | 47.415 | 2,40% | Azioni |
| JANE STREET GROUP, LLC | $76.154 | 36.092 | 1,83% | Azioni |
| NORTHERN TRUST CORP | $72.181 | 34.209 | 1,73% | Azioni |
| TWO SIGMA ADVISERS, LP | $34.547 | 17.900 | 0,83% | Azioni |
| LPL Financial LLC | $31.416 | 14.889 | 0,75% | Azioni |
| RAYMOND JAMES FINANCIAL INC | $31.363 | 14.864 | 0,75% | Azioni |
| StoneX Group Inc. | $24.745 | 11.153 | 0,59% | Azioni |
| Objectivity Squared, LLC | $23.031 | 10.915 | 0,55% | Azioni |
| Farther Finance Advisors, LLC | $19.940 | 9.450 | 0,48% | Azioni |
| UBS Group AG | $14.369 | 6.810 | 0,34% | Azioni |
| Vanguard Global Advisers, LLC | $6.203 | 2.940 | 0,15% | Azioni |
| Bay Harbor Wealth Management, LLC | $2.865 | 1.358 | 0,07% | Azioni |
| IFS Advisors, LLC | $2.004 | 950 | 0,05% | Azioni |
| SBI Securities Co., Ltd. | $1.361 | 645 | 0,03% | Azioni |
| JONES FINANCIAL COMPANIES LLLP | $828 | 396 | 0,02% | Azioni |
| Caitong International Asset Management Co., Ltd | $557 | 264 | 0,01% | Azioni |
| BARCLAYS PLC | $523 | 248 | 0,01% | Azioni |
| CALDWELL SUTTER CAPITAL, INC. | $211 | 100 | 0,01% | Azioni |
| MATHER GROUP, LLC. | $177 | 84 | 0,00% | Azioni |
| HRT FINANCIAL LP | $47 | 22.430 | 0,00% | Azioni |
| Virtu Financial LLC | $33 | 15.803 | 0,00% | Azioni |
| PRICE T ROWE ASSOCIATES INC /MD/ | $29 | 13.318 | 0,00% | Azioni |
| Inspire Investing, LLC | $26 | 14 | 0,00% | Azioni |
Attivisti e proprietari del 5%+ 8 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| Roger L. Hawley, The Hawley Family Trust Dated October 22, 2004 ×4 depositi | 01 Aprile 2020 | · | Deposito iniziale | Campagna per il consiglio di amministrazione | SEC |
| Sabrina Martucci Johnson, Vincent S. Johnson and Sabrina M. Johnson Family Trust Dated February 14, 2005, Vincent S. Johnson ×3 depositi | 21 Febbraio 2020 | · | Deposito iniziale | · | SEC |
| Mark Walters, Walters Family Trust Dated January 15, 2009, Nancy Walters ×2 depositi | 16 Aprile 2019 | · | Deposito iniziale | · | SEC |
| Lisa Walters-Hoffert, Lisa Walters-Hoffert Survivor’s Trust dated October 31, 2002 ×2 depositi | 15 Aprile 2019 | · | Deposito iniziale | · | SEC |
| Polaris Venture Partners IV, L.P. (“PVP IV”), Polaris Venture Partners Entrepreneurs’ Fund IV, L.P. (“PVPE IV”), Polaris Venture Management Co. IV, L.L.C. (“PVM IV”), Jonathan A. Flint, Terrance G. McGuire ×2 depositi | 14 Febbraio 2019 | · | Deposito iniziale | · | SEC |
| Alan Crane ×2 depositi | 14 Febbraio 2019 | · | Deposito iniziale | · | SEC |
| Polaris Venture Partners V, L.P. (“PVP V”), Polaris Venture Partners Entrepreneurs’ Fund V, L.P. (“PVPE V”), Polaris Venture Partners Founders’ Fund V, L.P. (“PVPFF V”), Polaris Venture Partners Special Founders’ Fund V, L.P. (“PVPSFF V”), Polaris Venture Management Co. V, L.L.C. (“PVM V”), Jonathan A. Flint, Terrance G. McGuire ×2 depositi | 14 Febbraio 2019 | · | Deposito iniziale | · | SEC |
| Daré Bioscience, Inc. | 28 Marzo 2017 | · | Deposito iniziale | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insider aziendali 30 insider · 13 dirigenti · 17 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Christopherd T Guiffre | Chief Executive Officer | 06 Gennaio 2017 A | 12.489 | 0 | 0 | $0 |
| Oliver Fetzer | President and CEO | 24 Giugno 2014 A | 30.000 | 0 | 0 | $0 |
| Lisa Walters-Hoffert | Chief Financial Officer | 24 Gennaio 2023 A | 443.512 | 0 | 0 | $0 |
| Gregg Beloff | CFO | 05 Gennaio 2017 A | · | 0 | 0 | $0 |
| Sabrina Martucci Johnson | Chef Executive Officer | 18 Febbraio 2026 A | 962.062 | 0 | 0 | $0 |
| Mardee Haring-Layton | Chief Accounting Officer | 30 Gennaio 2026 A | · | 0 | 0 | $0 |
| John A Fair | Chief Commercial Officer | 12 Marzo 2024 A | · | 0 | 0 | $0 |
| Scott Eliasof | SVP, Chief Scientific Officer | 05 Gennaio 2017 A | · | 0 | 0 | $0 |
| Alejandra Carvajal | VP, General Counsel | 05 Gennaio 2017 A | · | 0 | 0 | $0 |
| Adrian Senderowicz | SVP, Chief Medical Officer | 05 Gennaio 2017 A | · | 0 | 0 | $0 |
| James E Oneill | Principal Accounting Officer | 05 Gennaio 2017 A | 2.098 | 0 | 0 | $0 |
| Karen Lynn Roberts | Sr VP Finance & Administrat | 05 Febbraio 2015 A | · | 0 | 0 | $0 |
| Edward Graeme Garmey | Sr. VP, Chief Medical Officer | 05 Febbraio 2015 A | · | 0 | 0 | $0 |
| Jessica D. Grossman | Direttore | 30 Giugno 2026 A | 26.066 | 0 | 0 | $0 |
| Gregory W Matz | Direttore | 30 Giugno 2026 A | 30.847 | 0 | 0 | $0 |
| Susan L. Kelley | Direttore | 30 Giugno 2026 A | 23.696 | 0 | 0 | $0 |
| Robin Joan Steele | Direttore | 30 Giugno 2026 A | 47.055 | 0 | 0 | $0 |
| William H Rastetter | Direttore | 30 Giugno 2026 A | 39.721 | 0 | 0 | $0 |
| Sophia Nnenna Ononye-Onyia | Direttore | 21 Giugno 2023 A | · | 0 | 0 | $0 |
| Cheryl R Blanchard | Direttore | 21 Giugno 2023 A | · | 0 | 0 | $0 |
| Paul A Friedman, M.D. | Direttore | 03 Aprile 2017 A | 18.819 | 0 | 0 | $0 |
| Stuart A Arbuckle | Direttore | 03 Gennaio 2017 A | 13.104 | 0 | 0 | $0 |
| David Ross Parkinson | Direttore | 03 Gennaio 2017 A | 28.488 | 0 | 0 | $0 |
| William Mckee | Direttore | 03 Gennaio 2017 A | 3.418 | 0 | 0 | $0 |
| David R Walt | Direttore | 03 Gennaio 2017 A | 193.700 | 0 | 0 | $0 |
| Alan L Crane | Direttore | 22 Giugno 2016 A | 4.771.739 | 0 | 0 | $0 |
| Steven Edward Hall | Direttore | 26 Giugno 2015 A | 2.356.227 | 0 | 0 | $0 |
| CVF, LLC | Proprietario del 10% | 07 Aprile 2015 P | 2.592.577 | 0 | 0 | $0 |
| Roger Hawley | · | 13 Giugno 2019 A | 944.956 | 0 | 0 | $0 |
| Rock Springs Capital Management LP | · | 15 Aprile 2014 C | 464.365 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Proprietà ETF Posseduti da 3 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
DARE Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
rating · 9 analisti
COMPRA
Target mediano
$8.00
+849,2%
2 22,2%
Acquisto forte
6 66,7%
Compra
1 11,1%
Mantieni
0 0,0%
Vendi
0 0,0%
Vendita forte
Target Price a 12 Mesi
3 analisti · 2026-10-03Target medio $8.33 +888,8%
← Sotto tutti i target
Prezzo attuale $0.84
Basso$5.00
Media$8.33
Alto$12.00
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| DARE | $28M | -1.6 | 10429.4% | -1300.7% | 270.9% | · |
| RKTO | · | · | · | · | · | · |
| LPCN | $49M | -4.8 | -82.3% | -487.1% | -60.9% | · |
| TVRD | $40M | -1.3 | -66.0% | · | -67.6% | · |
| BFRI | · | · | · | · | · | · |
| CTXR | · | -0.4 | · | · | · | · |
| HIND | $20M | -0.7 | 24.4% | -3209.7% | -411.1% | 68.4% |
| CALC | · | -3.3 | -29.7% | · | · | · |
| LLY | · | 46.8 | 44.7% | 31.7% | 101.2% | · |
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Fonte: SEC 10-Q depositato Ago 13, 2026